BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Patent News (World)
Drawbridge Pharmaceuticals Announces Successful Clinical Trial Results For Phaxan™ And Grant Of U.S. Patent 4/16/2014  More...
Depomed, Inc. (DEPO) Announces Settlements With Two Gralise® ANDA Filers 4/14/2014  More...
Critical Pharmaceuticals Limited Receives Notice Of Allowance From US Patent And Trademark Office For Intranasal Growth Hormone And Parathyroid Hormone Products 4/8/2014  More...
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014  More...
Enzymotec Provides Update On Patent Litigation With Neptune Technologies & Bioressources Inc. 4/1/2014  More...
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In U.S.A. 3/26/2014  More...
Merck & Co., Inc. (MRK) HIV Drug Strategy Seen Shielding Patent 3/21/2014  More...
Actavis (ACT) Announces Daytrana® Patent Challenge Settlement 3/20/2014  More...
Settlement Between BioPorto And Phadia AB In Patent Case 3/3/2014  More...
Fibrotech Is Granted U.S. And Canadian Patents For Its Anti-Fibrotic Compounds 3/3/2014  More...
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 2/25/2014  More...
Can-Fite BioPharma (CFBI) Granted Patent On The Manufacturing Of CF101 In Japan 2/25/2014  More...
ISA Pharmaceuticals Strengthens Patent Protection For Its Lead Product ISA101 2/24/2014  More...
Scancell: Publication Of Moditope Patent 2/18/2014  More...
Pluristem Therapeutics (PSTI) Receives Key 3D Cell Expansion Patent In Australia 2/18/2014  More...
BioAlliance Pharma: Strengthening And Extension Of The Industrial Protection Of Livatag® Until 2031 2/18/2014  More...
OvaScience (OVAS) Issued Two U.S. Patents Covering AUGMENT? Fertility Treatment 2/12/2014  More...
Actavis (ACT) Confirms Generic Treanda® Patent Challenge 2/4/2014  More...
Enzymotec Announces It Has Been Granted Patents For INFAT®'S Uses In Canada And The US 2/3/2014  More...
Suven Life Sciences Ltd Product Patents For Their NCEs In Canada, China And India 1/31/2014  More...
Microbix Biosystems Inc. (MBXBF) Wins VIRUSMAX® Patent Challenge In Europe 1/23/2014  More...
Anergis Obtains Core Technology Patent In Japan 1/14/2014  More...
Adocia Strengthens Its Diabetic Foot Ulcer Patent Portfolio 1/13/2014  More...
BrainStorm Cell Therapeutics Inc. Receives United States Patent Office Notice Of Allowance For Its Stem Cell Technology 1/13/2014  More...
Suven Life Sciences Ltd Three (3) Product Patents For Their Nces In Australia, Sri Lanka And South Korea 1/9/2014  More...
Pluristem Therapeutics (PSTI) Receives Key Placental Cell Therapy Patent in Australia 1/8/2014  More...
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance To Grant European Patent Covering Its Stem Cells For The Treatment Of CNS Diseases 1/8/2014  More...
Veloxis Pharmaceuticals A/S (VELO) Receives Notice Of Allowance From U.S. Patent Office For Diurnal-Independent Administration Of Envarsus® 1/8/2014  More...
Enzymotec Granted Patent For A Lipid Preparation Use Method 1/6/2014  More...
Actavis (ACT) Confirms Generic NuvaRing® Patent Challenge 12/27/2013  More...
Caris Life Sciences Receives Patent For Molecular Profiling Service In The People's Republic Of China 12/17/2013  More...
Scancell's DNA ImmunoBody® Patent Granted In Japan 12/12/2013  More...
MorphoSys AG Strengthens European Patent Position On Anti-CD19 Cancer Program MOR208 12/3/2013  More...
Amarin Corporation PLC (AMRN) Announces Notification Of Patent Allowances For U.S. Applications 13/685,281, And 13/685,291 Related To Triglyceride Lowering With A Mixture Of Omega-3 Free Fatty Acid (Including EPA And/Or DHA) In Both The MARINE And ANCHOR Patient Populations 12/2/2013  More...
TopoTarget A/S Release: Allowance Of Key Belinostat Patent In Europe 11/21/2013  More...
Plasticell Release: Additional Family Of CombiCult® Patents Granted In USA, Europe, Australia And Singapore 11/18/2013  More...
BioAlliance Pharma Strengthens Sitavig Patent Protection With New U.S. And South Korean Issued Patents 11/14/2013  More...
Zysis Receives U.S. Patent for Long Acting Oral Aripiprazole Once Weekly 11/13/2013  More...
Can-Fite BioPharma (CFBI) Release: U.S. Patent and Trademark Office Grants a Patent for the Reduction of Intraocular Pressure 11/6/2013  More...
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their NCEs in U.S.A. and Japan 11/6/2013  More...
Enzymotec Granted Patent for Its Composition of Vayacog® Addressing Memory and Mild Cognitive Impairment 10/30/2013  More...
Drawbridge Pharmaceuticals Granted New Anaesthesia Patents for Phaxan™ 10/28/2013  More...
Immunicum's Patent Application Regarding the Company’s Core-Technology for Therapeutic Cancer Vaccination Using Allogeneic Dendritic Cells is Being Approved in the U.S. 10/25/2013  More...
Merus Granted European Patent on MeMo®, a Transgenic Mouse for Generating the Building Blocks of Therapeutic Human Bispecific Antibodies 10/23/2013  More...
Mystic Pharmaceuticals Receives Notices of Allowance From Japan and China on Drug Delivery Platform Technologies 10/1/2013  More...
Suven Life Sciences Ltd Secures Three (3) Product Patents for Their New Chemical Entities, Inc.'s in New Zealand, Singapore and South Korea 9/25/2013  More...
Mylan Inc. (MYL) Will Not Shy Away From Pursuing "Frivolous" Patents 9/12/2013  More...
Pluristem Therapeutics (PSTI) Granted Key U.S. Patent for the Treatment of Peripheral Artery Disease 9/11/2013  More...
Roche (RHHBY) Gives Up on India Patent for Breast Cancer Drug 8/16/2013  More...
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their New Chemical Entities, Inc.'s in Europe 8/8/2013  More...
Roche (RHHBY) Cancer Drug Suffers Patent Setback in India 8/6/2013  More...
China's SIPO Voids Patent for Gilead Sciences, Inc. (GILD)'s Viread 7/30/2013  More...
Indian Ministry Wants to Cancel Patent on Roche (RHHBY) Cancer Drug 7/26/2013  More...
Riboxx Announces RNA Manufacturing Patent Grant by EPO 7/17/2013  More...
Genetic Technologies Limited (GTG.AX) Announces U.S. Patent Office Allows First Patent for ImmunAid 7/10/2013  More...
Suven Life Sciences Ltd Secures Two Product Patents for Their NCEs in Japan and U.S.A. 6/28/2013  More...
As Field Hots Up, Virttu Biologics Secures U.S. Patent Allowance on Next-Generation Oncolytic Virus Candidates Engineered to Express Antisense Sequences 6/25/2013  More...
Kamada Ltd. (KMDA.TA) Granted Two Key Patents 6/24/2013  More...
Anergis Files Provisional U.S. Patent on AllerDM Dust Mite Allergy Treatment 6/13/2013  More...
QRxPharma Pty Ltd. Granted US Patent on Hybrid Opioids 6/12/2013  More...
Patrys Limited (PAB.AX) Granted Key Patent for Lead Product – PAT-LM1 6/7/2013  More...
Verva Pharmaceuticals Announces Grant of United States Patent for Type 2 Diabetes Therapy VVP808 and Results of Annual General Meeting 6/3/2013  More...
Ockham Overturns Vectura Group plc (VEC.L)'s Challenge to Secure European Patent Rights for Inhaled Heparin in the Treatment of COPD 6/3/2013  More...
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa® and Statin Therapy 5/22/2013  More...
New Japanese Protozoal Patent for BioDiem Ltd. (BDM.AX)'s BDM-I 5/22/2013  More...
European and U.S. Cellulase Patents Granted to DIREVO Industrial Biotechnology GmbH 5/21/2013  More...
Biotage AB (BIOTa.ST) and Peptide Synthesis 5/13/2013  More...
Suven Life Sciences Ltd Secures Three Product Patents for Their NCEs in Canada and Eurasia 5/10/2013  More...
Novartis AG (NVS) Sees Boost From Program Designed to Speed Life-Saving Therapies 5/6/2013  More...
Imugene Limited (IMU.AX) Granted Chinese Patent for Novel Drug Delivery Technology 4/30/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Welcomes Landmark "Victory for Patient" in Intellectual Property Case 4/30/2013  More...
GW Pharmaceuticals Announces U.S. Patent Allowance for SATIVEX® Formulation Spray Device 4/22/2013  More...
ARTES Biotechnology Issued New Patent in Australia for VLP Technology 4/22/2013  More...
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant 4/22/2013  More...
Medgenics, Inc. Receives Notice of Allowance From the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins 4/22/2013  More...
Starpharma Holdings Ltd Granted New Drug Delivery Patents 4/17/2013  More...
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in China, Mexico and New Zealand 4/17/2013  More...
Prima Biomed (PRR.AX) Awarded Japanese Patent for CVac™ 4/17/2013  More...
Celsus Therapeutics Announces Notification of Patents Granted 4/17/2013  More...
Glenmark Pharmaceuticals to Respond to Patent Row With Merck & Co., Inc. (MRK) Next Month 4/15/2013  More...
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S. 4/2/2013  More...
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case 4/1/2013  More...
European Patent Office to Grant Patent for Macrocure's CureXcell® 3/21/2013  More...
Genetic Technologies Limited (GTG.AX) Provides U.S. Patent Re-Examination Update 3/15/2013  More...
Allergy Therapeutics plc Granted U.S. Patent for Sublingual Administration of MPL Adjuvant and Vaccine Antigens 3/11/2013  More...
Alchemia Granted Key U.S. Patent 3/6/2013  More...
India Rejects Bayer AG (BAY.F) Plea Against Cheap Cancer Drug 3/5/2013  More...
Additional Patent Granted in China for BioDiem Ltd. (BDM.AX)'s Antimicrobial 2/21/2013  More...
BioIndustry Association Release: New Patent Court Makes UK Natural European Home for Global Life Science Businesses 2/19/2013  More...
Bristol-Myers Squibb Company (BMY): Patent on $1.4 Billion Hepatitis-B Treatment Invalid; Teva Pharmaceutical Industries Limited (TEVA) to Benefit 2/13/2013  More...
Biotech Support Group Release: Use of Cleanascite™ in "Method and Pharmaceutical Composition for Treatment of Intestinal Disease" 2/12/2013  More...
MorphoSys AG Receives First Patent on Novel Antibody Platform Ylanthia in the U.S. 2/8/2013  More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance From Chinese Patent Office for Treatment and Prevention of Heart Disease 2/8/2013  More...
Mesoblast Limited Release: Key Mesenchymal Precursor Cell Patents Granted in United States and China 2/7/2013  More...
AmpliPhi Biosciences (TGEN) Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-Resistant Biofilm-based Infections 2/4/2013  More...
Amarin Corporation PLC (AMRN) Announces Notification of Additional U.S. Patent Allowance for U.S. Application 13/272,520 Based on ANCHOR Clinical Trial Results 2/1/2013  More...
Amarin Corporation PLC (AMRN) Announces Notification of Two Additional Patent Allowances for U.S. Applications (13/458,496 and 13/349,157) Related to Vascepa® and FDA Approved MARINE Indication 1/31/2013  More...
Amarin Corporation PLC (AMRN) Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results 1/24/2013  More...
Anergis Obtains U.S. Patent for Lead Product AllerT 1/23/2013  More...
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad U.S. Composition of Matter Patent for ADX71441 1/22/2013  More...
Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™ 1/22/2013  More...
Biotage AB (BIOTa.ST) Success in Re-Examination Proceedings 1/16/2013  More...
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa® and FDA Approved MARINE Indication 1/11/2013  More...
RedHill Biopharma Ltd. (RDHL) Announces Issuance of New U.S. Patent and Provides Update on RHB-104 for Treatment of Crohn's Disease 1/7/2013  More...
Alkermes plc (ALKS) Announces Notice of Allowance of Key U.S. Patent for Aripiprazole Lauroxil, a New Schizophrenia Drug Candidate 1/3/2013  More...
Suven Life Sciences Ltd Secures 3 Product Patents for Their New Chemical Entities, Inc.'s in Eurasia & Canada 1/2/2013  More...
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa® and FDA Approved MARINE Indication 12/13/2012  More...
MorphoSys AG Strengthens Patent Position on anti-CD38 Cancer Program MOR202 12/6/2012  More...
Medgenics, Inc. Key Patent Claims Allowed in Japan Protecting Core Technology to be Used in Hepatitis Treatment 12/6/2012  More...
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan 12/5/2012  More...
Rainbow BioSciences, LLC Target Amarantus BioSciences, Inc. Wins MANF Patent Challenge in Europe 12/5/2012  More...
Axiogenesis Earns U.S. Patent With In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy 12/4/2012  More...
Indian Board Rejects AstraZeneca PLC (AZN)'s Patent Plea on Cancer Drug 11/28/2012  More...
Rhenovia Files Two Patent Applications for RHEpatch™, an Electronic Transdermal Patch for Controlled Drug Delivery 11/28/2012  More...
Medgenics, Inc. Granted U.S. Patent for Core Technology Used in Sustained Delivery of Erythropoietin, Aimed at Multi-Billion Dollar Anemia Market 11/21/2012  More...
Japanese Patent Office to Grant BioDiem Ltd. (BDM.AX) New Patent for BDM-I Antimicrobial 11/21/2012  More...
Marinomed Biotechnologie GmbH Granted Chinese Patent for Antiviral Polymer 11/19/2012  More...
MediciNova, Inc. Extends MN-166 Patent Position in Europe 11/19/2012  More...
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/608,775 Related to Vascepa® and FDA Approved MARINE Indication 11/19/2012  More...
New Patent Covering PROLOR Biotech (PBTH)'s Reversible-Pegylation Platform Technology is Allowed by U.S. Patent Office 11/13/2012  More...
India Revokes Roche (RHHBY) Patent in New Blow for Big Pharma 11/5/2012  More...
InDex Pharmaceuticals AB Granted Japanese Patent for Novel Treatment of Steroid-Resistant Inflammation 10/24/2012  More...
Amarin Corporation PLC (AMRN) Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa™ 10/23/2012  More...
Adocia is Extending Its Intellectual Property to New Formulations of Monoclonal Antibodies 10/22/2012  More...
InteRNA Technologies Receives Notice of Allowance for miRNA Sequences of Its Lead Pre-Clinical Product 10/15/2012  More...
Laurantis Pharma Oy Issued Patent for Cis-UCA as a Treatment for Bladder Cancer 10/9/2012  More...
Alnylam Pharmaceuticals (ALNY) Announces Tuschl II Key Patent Claims Upheld in Invalidation Trial in Japan 10/9/2012  More...
India Revokes Patent for Pfizer Inc. (PFE)'s Sutent 10/4/2012  More...
Suven Life Sciences Ltd Bags Pharmexcil's "Platinum Patent Award" 10/4/2012  More...
BioLineRx Ltd. Receives Notice of Allowance From USPTO for New Patent on BL-1020, Extending Patent Protection Until 2031 9/24/2012  More...
Cardiolynx Receives Patent on Improved Angina Pectoris Drug 9/20/2012  More...
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/284,408 Related to Vascepa™ and FDA Approved MARINE Indication 9/6/2012  More...
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa™ and FDA Approved MARINE Indication 9/5/2012  More...
Public Not to be Hit if Natco Pharma Limited Licence Cancelled: Bayer Corporation (BAY) 9/4/2012  More...
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/282,145 Related to Vascepa™ and FDA Approved MARINE Indication 9/4/2012  More...
InDex Pharmaceuticals AB Strengthens IP Position for Kappaproct 9/4/2012  More...
U.S. Patent Granted for Verona Pharma's RPL554 8/28/2012  More...
China Botanic Receives New Patent on Its Comprehensive Method to Enhance the Medicinal Value of Schisandra 8/28/2012  More...
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in Australia, Canada, Korea and New Zealand 8/9/2012  More...
BioDiem Ltd. (BDM.AX) Granted European Patent for BDM-I Antimicrobial 8/7/2012  More...
DiaGenic ASA: Notice of Allowance of Breast Cancer Patent in Japan 8/3/2012  More...
U.S. Patent Office Allows Laurantis Pharma Oy Application for Treatment of Skin Inflammation 8/1/2012  More...
Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments 7/30/2012  More...
Amarin Corporation PLC (AMRN) Receives Notice of Intention to Grant on European Patent 7/25/2012  More...
BioAlliance Pharma Extends and Strengthens the Protection of AMEP® With the Grant of Two Patents in the US 7/12/2012  More...
Novartis AG (NVS) India Patent Case Postponed to August 22 7/9/2012  More...
BioLineRx Ltd. Receives Notice of Intention to Grant Additional European Patent Covering BL-1020, for the Treatment of Schizophrenia 7/9/2012  More...
Danisco Wins European Patent Office Appeal as Board Revokes Novozymes A/S (NZYMb.CO) Animal Feed Patent 7/6/2012  More...
Amarin Corporation PLC (AMRN) Announces Notice of Allowance for Additional U.S. Patent Covering AMR101 7/2/2012  More...
PolyTherics Granted Further Patents for TheraPEG™ and GlycoPol™ 6/18/2012  More...
InnaVirVax Strenghtens Patent Protection of VAC-3S Immunotherapy 6/18/2012  More...
Bionor Pharma ASA Release: International Patent Application Submitted Covering Vaccines for Influenza (Universal Vaccine), Hepatitis C, Cytomegalovirus and Human Papillomavirus 6/7/2012  More...
Bionor Pharma ASA Release: International Patent Application Submitted for the Therapeutic and Potentially Preventive Vaccine Vacc-HIV, Combining Bionor's Vacc-4x and Vacc-C5 6/7/2012  More...
BioLineRx Ltd. Announces Receipt of Two Notices of Allowance from USPTO for Patents Covering BL-1021, an Orally Available New Chemical Entity for Treatment of Neuropathic Pain 6/5/2012  More...
Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform 5/31/2012  More...
Amarin Corporation PLC (AMRN) Announces U.S. Patent Issuance for AMR101 5/29/2012  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Core Technology Patent in New Zealand 5/29/2012  More...
Patrys Limited (PATZF.PK) Granted Key Patent for Lead Product -- PAT-SM6 5/24/2012  More...
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in Japan, Australia, Europe and Eurasia 5/22/2012  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins 5/16/2012  More...
New US Patent Grant for ValiRx Plc's Cancer Screening Gene Biomarker 5/15/2012  More...
Agenix Limited: New Patent Granted in Japan Enhances Value of Revolutionary New Australian Blood Clot Diagnostic Technology 5/14/2012  More...
Nitto Denko Corporation (XETRA: ND5.DE) Obtains US Patent for Antifibrotic Therapies with Molecular Targeting DDS Technology 5/10/2012  More...
BioDiem Ltd. (BDM.AX) Release: BDM-I Patent Position Strengthened With New US Patent Relating to Malaria and Trichomoniasis 5/3/2012  More...
Quotient Receives Final Patent Approval for Its Enteriontm Technology – the Industry's Leading Clinical Technology for Investigating Drug Absorption 5/1/2012  More...
U.S. Court Invalidates Two Sanofi (France) (SAN.PA) Taxotere Patents 4/11/2012  More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Four New Patents and Allowances in Mexico and Israel 4/9/2012  More...
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in China and Korea 4/3/2012  More...
Supreme Court Knocks Back Myriad Genetics, Inc. (MYGN) Patents 3/28/2012  More...
Ideal Cures Pvt. Ltd. Receives Key US Patent for Sodium Alginate Based Aqueous Film Coating Technology 3/27/2012  More...
Genmab A/S (GEN.CO) Says GlaxoSmithKline (GSK) Settles Patent Case With Genentech (RHHBY) 3/27/2012  More...
Moraga Biotechnology Corporation Announces Issuance of Adult Stem Cell Patent for Humans 3/20/2012  More...
Silence Therapeutics plc and Other Opponents of Tuschl I Patent Succeed in Limiting Scope and Ambiguity in the Patent 3/9/2012  More...
BioLineRx Ltd. Announces Grant of European Patent Covering BL-1020, an Orally Available Treatment for Schizophrenia 3/7/2012  More...
Alnylam Pharmaceuticals (ALNY) and the University of Massachusetts Medical School Announce Tuschl I Patent Upheld in European Opposition Proceedings 3/1/2012  More...
Genetic Technologies Limited (GTG.AX) Provides Update on U.S. and Australian Gene Patenting Litigation, Case Law and Legislation 2/29/2012  More...
GENFIT Corp. (ALGFT) Release: GFT505: New Patents Granted in Major Countries 2/23/2012  More...
Hatchtech Extends Patent Protection for DeOvo™ Head Lice Treatment 2/15/2012  More...
Precision BioSciences Receives Notice of Intent to Grant for New European Patent Covering Engineered Meganucleases 2/14/2012  More...
Plasticell Announces Grant of Fundamental Combicultt Patents in USA and Japan 2/13/2012  More...
Sanofi (France) (SAN.PA), Bristol-Myers Squibb Company (BMY) Receive Nearly $445 Million From Apotex Inc. Over Generic Plavix 2/9/2012  More...
Suven Life Sciences Ltd Secures 3 Product Patents for Their NCEs in Mexico and USA 2/7/2012  More...
Precision BioSciences Announces Allowance of Third U.S. Patent Related to Engineered Meganucleases 1/30/2012  More...
Affectis Pharmaceuticals AG Granted Patent for AFC-5128, Other P2X7 Antagonists 1/25/2012  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins 1/24/2012  More...
MorphoSys AG Strengthens Patent Position on MOR202 Program 1/23/2012  More...
With Final Documentation Submitted for International Patent Applications, Bionor Pharma ASA Sees Promise of Two Core Platform Technologies 1/23/2012  More...
Seegene, Inc. Strengthens Position in Multiplex PCR With Award of United States Patent for Dual Priming Oligonucleotide (DPO(TM)) Technology 1/17/2012  More...
Biotage AB (BIOTa.ST) is Subject to Extended Patent Litigation in the US 1/12/2012  More...
Pulmatrix Announces Grant of Patent Supporting Its Novel Pulmonary Drug Therapies 1/5/2012  More...
European Patent Office Upholds Synergy Pharmaceuticals’ Grant of Claims to Plecanatide 1/4/2012  More...
Nuvilex Associate Expands Ownership of Patents to Include Production of Therapeutic Antibodies 12/20/2011  More...
Ablynx Adds Another Key Patent to Its Expanding Patent Estate Around Half-Life Extension 12/15/2011  More...
Pharming Group (PHGUF.PK) Granted U.S. Patent on C1 Inhibitor Use in Ischemia Reperfusion Injury Indications 12/12/2011  More...
Silence Therapeutics plc Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents 12/12/2011  More...
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in Australia and Canada 12/8/2011  More...
Silence Therapeutics plc Announces Positive Outcome From Oral Hearing at the European Patent Office 12/7/2011  More...
MEDA: Astepro Patent Granted 12/6/2011  More...
PRANA Biotechnology (PRAN) Secures Key Patent for Parkinson's Drug PBT434 in the United States 11/28/2011  More...
AusBiotech Ltd. Supports Government's Response on Patents 11/28/2011  More...





 

//-->